133 related articles for article (PubMed ID: 10775052)
1. K-ras point mutations in spontaneously occurring endometrial adenocarcinomas in the Donryu rat.
Tanoguchi K; Yaegashi N; Jiko K; Maekawa A; Sato S; Yajima A
Tohoku J Exp Med; 1999 Oct; 189(2):87-93. PubMed ID: 10775052
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
[TBL] [Abstract][Full Text] [Related]
4. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.
Mutter GL; Wada H; Faquin WC; Enomoto T
Mol Pathol; 1999 Oct; 52(5):257-62. PubMed ID: 10748874
[TBL] [Abstract][Full Text] [Related]
5. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
Inoue M
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
[TBL] [Abstract][Full Text] [Related]
6. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia.
Sun H; Enomoto T; Shroyer KR; Ozaki K; Fujita M; Ueda Y; Nakashima R; Kuragaki C; Ueda G; Murata Y
Diagn Mol Pathol; 2002 Dec; 11(4):204-11. PubMed ID: 12459636
[TBL] [Abstract][Full Text] [Related]
8. K-ras exon 2 point mutations in human endometrial cancer.
Semczuk A; Schneider-Stock R; Berbec H; Marzec B; Jakowicki JA; Roessner A
Cancer Lett; 2001 Mar; 164(2):207-12. PubMed ID: 11179836
[TBL] [Abstract][Full Text] [Related]
9. K-ras activation in neoplasms of the human female reproductive tract.
Enomoto T; Inoue M; Perantoni AO; Terakawa N; Tanizawa O; Rice JM
Cancer Res; 1990 Oct; 50(19):6139-45. PubMed ID: 2205377
[TBL] [Abstract][Full Text] [Related]
10. ras gene mutations in human endometrial carcinoma.
Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
[TBL] [Abstract][Full Text] [Related]
11. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
12. Studies on ras oncogene activation in endometrial carcinoma.
Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
[TBL] [Abstract][Full Text] [Related]
13. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.
Sasaki H; Nishii H; Takahashi H; Tada A; Furusato M; Terashima Y; Siegal GP; Parker SL; Kohler MF; Berchuck A
Cancer Res; 1993 Apr; 53(8):1906-10. PubMed ID: 8467512
[TBL] [Abstract][Full Text] [Related]
14. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer.
Sagawa M; Saito Y; Fujimura S; Linnoila RI
Br J Cancer; 1998 Mar; 77(5):720-3. PubMed ID: 9514049
[TBL] [Abstract][Full Text] [Related]
15. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
[TBL] [Abstract][Full Text] [Related]
16. ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene.
McKinzie PB; Delongchamp RR; Chen T; Parsons BL
Mutagenesis; 2006 Nov; 21(6):391-7. PubMed ID: 17012303
[TBL] [Abstract][Full Text] [Related]
17. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin.
Fowler ML; Sigler RE; de la Iglesia FA; Reddy JK; Lalwani ND
Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083
[TBL] [Abstract][Full Text] [Related]
18. K-ras codon 12 and 61 point mutations in bromodeoxyuridine- and N-nitrosomethylurea-induced rat renal mesenchymal tumors.
Calvert RJ; Buzard GS; Anisimov VN; Rice JM
Cancer Lett; 1996 Dec; 109(1-2):1-7. PubMed ID: 9020896
[TBL] [Abstract][Full Text] [Related]
19. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986.
Richardson KK; Helvering LM; Copple DM; Rexroat MA; Linville DW; Engelhardt JA; Todd GC; Richardson FC
Carcinogenesis; 1992 Jun; 13(6):935-41. PubMed ID: 1350949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
